CRISPR Therapeutics (CRSP)
50.50
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 CRISPR Therapeutics AG For: Oct 19 Filed by: Silver Andrew Jacob
October 21, 2026 5:42 PM - SEC Filing
Form 3 CRISPR Therapeutics AG For: Oct 19 Filed by: Silver Andrew Jacob
October 21, 2026 5:36 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Oct 16 Filed by: Kulkarni Samarth
October 20, 2026 5:35 PM - SEC Filing
Form 8-K CRISPR Therapeutics AG For: Oct 19
October 19, 2026 4:11 PM - SEC Filing
CRISPR Therapeutics names A.J. Silver as new CFO
October 19, 2026 4:05 PM - StreetInsider
CRISPR Therapeutics Announces Chief Financial Officer Transition
October 19, 2026 4:05 PM - Globe NewsWire
Form 4 CRISPR Therapeutics AG For: Oct 14 Filed by: George Simeon
October 16, 2026 5:46 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Oct 13 Filed by: KASINGER JAMES R.
October 15, 2026 5:35 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Oct 13 Filed by: Kulkarni Samarth
October 15, 2026 5:35 PM - SEC Filing
UBS Starts CRISPR Therapeutics (CRSP) at Neutral
October 14, 2026 4:45 PM - StreetInsider
Form 144 CRISPR Therapeutics AG Filed by: George Simeon
October 14, 2026 4:17 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
October 9, 2026 6:51 AM - StreetInsider
Form 4 CRISPR Therapeutics AG For: Oct 06 Filed by: KASINGER JAMES R.
October 8, 2026 5:35 PM - SEC Filing
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026
October 8, 2026 8:30 AM - Globe NewsWire
Form 144 CRISPR Therapeutics AG Filed by: KASINGER JAMES R.
October 6, 2026 4:47 PM - SEC Filing
CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
October 2, 2026 10:15 AM - Globe NewsWire
Form 4 CRISPR Therapeutics AG For: Sep 22 Filed by: KASINGER JAMES R.
September 28, 2026 11:50 AM - SEC Filing
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens on Pipeline Opportunity
September 28, 2026 4:30 AM - StreetInsider
Form 4 CRISPR Therapeutics AG For: Sep 22 Filed by: KASINGER JAMES R.
September 24, 2026 5:35 PM - SEC Filing
Anthropic's Claude AI identifies novel enzyme system in DNA search
September 23, 2026 2:07 PM - StreetInsider
Form 144 CRISPR Therapeutics AG Filed by: KASINGER JAMES R.
September 22, 2026 4:43 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Sep 17 Filed by: Behbahani Ali
September 21, 2026 6:41 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Aug 06 Filed by: Behbahani Ali
September 21, 2026 6:30 PM - SEC Filing
Form 144 CRISPR Therapeutics AG Filed by: Behbahani Ali
September 17, 2026 4:09 PM - SEC Filing
Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
September 1, 2026 9:07 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
August 31, 2026 6:51 AM - StreetInsider
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens on CTX310 Data
August 31, 2026 5:02 AM - StreetInsider
CRISPR Therapeutics reports one-year CTX310 lipid-lowering data
August 28, 2026 10:31 AM - StreetInsider
CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026
August 28, 2026 10:31 AM - Globe NewsWire
CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens
August 25, 2026 4:11 AM - StreetInsider
Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: ORBIS INVESTMENT MANAGEMENT LTD
August 14, 2026 1:28 PM - SEC Filing
Form 4 CRISPR Therapeutics AG For: Aug 07 Filed by: Prasad Raju
August 11, 2026 5:36 PM - SEC Filing
Agomab proposes two new board members ahead of shareholder vote
August 10, 2026 4:08 PM - StreetInsider
Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
August 10, 2026 4:08 PM - StreetInsider
Agomab proposes two new board members ahead of shareholder vote
August 10, 2026 4:07 PM - StreetInsider
Form 10-Q CRISPR Therapeutics AG For: Jun 30
August 3, 2026 4:32 PM - SEC Filing
CRISPR Therapeutics (CRSP) Tops Q2 EPS by 26c
August 3, 2026 4:26 PM - StreetInsider
Form 8-K CRISPR Therapeutics AG For: Aug 03
August 3, 2026 4:25 PM - SEC Filing
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
August 3, 2026 4:15 PM - Globe NewsWire
Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: BlackRock, Inc.
July 27, 2026 4:26 PM - SEC Filing
Full Article List
